Halozyme Therapeutics shares owned by Mutual Of America Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Mutual Of America Capital Management
from 13F filings
Historical chart of Mutual Of America Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Mutual Of America Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Mutual Of America Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $5.7M | 140k | 40.68 |
| 2023-12-31 | $5.5M | 148k | 36.96 |
| 2023-09-30 | $5.9M | 155k | 38.20 |
| 2023-06-30 | $6.1M | 170k | 36.07 |
| 2023-03-31 | $7.2M | 188k | 38.19 |
| 2022-12-31 | $11M | 194k | 56.90 |
| 2022-09-30 | $7.6M | 193k | 39.54 |
| 2022-06-30 | $9.0M | 205k | 44.00 |
| 2022-03-31 | $5.1M | 128k | 39.88 |
| 2021-12-31 | $5.1M | 126k | 40.21 |
| 2021-09-30 | $5.1M | 125k | 40.68 |
| 2021-06-30 | $5.4M | 119k | 45.41 |
| 2021-03-31 | $4.8M | 115k | 41.69 |
| 2020-12-31 | $5.1M | 119k | 42.71 |
More positions owned by Mutual Of America Capital Management
View all positions for Mutual Of America Capital Management